<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Ricardo</forename><surname>Celestino</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Molecular Oncology</orgName>
								<orgName type="department" key="dep2">Institute for Cancer Research</orgName>
								<orgName type="institution" key="instit1">Norwegian Radium Hospital</orgName>
								<orgName type="institution" key="instit2">Oslo University Hospital</orgName>
								<address>
									<postBox>P.O.Box 4953</postBox>
									<postCode>0424</postCode>
									<settlement>Nydalen, Oslo</settlement>
									<country key="NO">Norway</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">i3S -Instituto de Investigação e Inovação em Saúde</orgName>
								<orgName type="institution">Universidade do Porto</orgName>
								<address>
									<postCode>208, 4200-135</postCode>
									<settlement>Rua Alfredo Allen, Porto</settlement>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Torfinn</forename><surname>Nome</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Molecular Oncology</orgName>
								<orgName type="department" key="dep2">Institute for Cancer Research</orgName>
								<orgName type="institution" key="instit1">Norwegian Radium Hospital</orgName>
								<orgName type="institution" key="instit2">Oslo University Hospital</orgName>
								<address>
									<postBox>P.O.Box 4953</postBox>
									<postCode>0424</postCode>
									<settlement>Nydalen, Oslo</settlement>
									<country key="NO">Norway</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ana</forename><surname>Pestana</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">i3S -Instituto de Investigação e Inovação em Saúde</orgName>
								<orgName type="institution">Universidade do Porto</orgName>
								<address>
									<postCode>208, 4200-135</postCode>
									<settlement>Rua Alfredo Allen, Porto</settlement>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><forename type="middle">M</forename><surname>Hoff</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Molecular Oncology</orgName>
								<orgName type="department" key="dep2">Institute for Cancer Research</orgName>
								<orgName type="institution" key="instit1">Norwegian Radium Hospital</orgName>
								<orgName type="institution" key="instit2">Oslo University Hospital</orgName>
								<address>
									<postBox>P.O.Box 4953</postBox>
									<postCode>0424</postCode>
									<settlement>Nydalen, Oslo</settlement>
									<country key="NO">Norway</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><forename type="middle">Pedro</forename><surname>Gonçalves</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">i3S -Instituto de Investigação e Inovação em Saúde</orgName>
								<orgName type="institution">Universidade do Porto</orgName>
								<address>
									<postCode>208, 4200-135</postCode>
									<settlement>Rua Alfredo Allen, Porto</settlement>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Luísa</forename><surname>Pereira</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">i3S -Instituto de Investigação e Inovação em Saúde</orgName>
								<orgName type="institution">Universidade do Porto</orgName>
								<address>
									<postCode>208, 4200-135</postCode>
									<settlement>Rua Alfredo Allen, Porto</settlement>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bruno</forename><surname>Cavadas</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">i3S -Instituto de Investigação e Inovação em Saúde</orgName>
								<orgName type="institution">Universidade do Porto</orgName>
								<address>
									<postCode>208, 4200-135</postCode>
									<settlement>Rua Alfredo Allen, Porto</settlement>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Catarina</forename><surname>Eloy</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">i3S -Instituto de Investigação e Inovação em Saúde</orgName>
								<orgName type="institution">Universidade do Porto</orgName>
								<address>
									<postCode>208, 4200-135</postCode>
									<settlement>Rua Alfredo Allen, Porto</settlement>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Trine</forename><surname>Bjøro</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Manuel</forename><surname>Sobrinho-Simões</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">i3S -Instituto de Investigação e Inovação em Saúde</orgName>
								<orgName type="institution">Universidade do Porto</orgName>
								<address>
									<postCode>208, 4200-135</postCode>
									<settlement>Rua Alfredo Allen, Porto</settlement>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rolf</forename><forename type="middle">I</forename><surname>Skotheim</surname></persName>
							<email>rolf.i.skotheim@rr-research.no</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Molecular Oncology</orgName>
								<orgName type="department" key="dep2">Institute for Cancer Research</orgName>
								<orgName type="institution" key="instit1">Norwegian Radium Hospital</orgName>
								<orgName type="institution" key="instit2">Oslo University Hospital</orgName>
								<address>
									<postBox>P.O.Box 4953</postBox>
									<postCode>0424</postCode>
									<settlement>Nydalen, Oslo</settlement>
									<country key="NO">Norway</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Paula</forename><surname>Soares</surname></persName>
							<email>psoares@ipatimup.pt</email>
							<affiliation key="aff1">
								<orgName type="department">i3S -Instituto de Investigação e Inovação em Saúde</orgName>
								<orgName type="institution">Universidade do Porto</orgName>
								<address>
									<postCode>208, 4200-135</postCode>
									<settlement>Rua Alfredo Allen, Porto</settlement>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">7F88B73BFD66281D4441B0D3064B78EE</idno>
					<idno type="DOI">10.1186/s12885-017-3948-3</idno>
					<note type="submission">Received: 1 January 2017 Accepted: 20 December 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:34+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>CRABP1</term>
					<term>CILP</term>
					<term>C1QL1</term>
					<term>LCN2</term>
					<term>Cancer</term>
					<term>Thyroid</term>
					<term>Biomarker</term>
					<term>TCGA</term>
					<term>RNA sequencing</term>
					<term>Gene expression</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: The prognostic variability of thyroid carcinomas has led to the search for accurate biomarkers at the molecular level.</s><s>Follicular thyroid carcinoma (FTC) is a typical example of differentiated thyroid carcinomas (DTC) in which challenges are faced in the differential diagnosis.</s></p><p><s>Methods: We used high-throughput paired-end RNA sequencing technology to study four cases of FTC with different degree of capsular invasion: two minimally invasive (mFTC) and two widely invasive FTC (wFTC).</s><s>We searched by genes differentially expressed between mFTC and wFTC, in an attempt to find biomarkers of thyroid cancer diagnosis and/or progression.</s><s>Selected biomarkers were validated by real-time quantitative PCR in 137 frozen thyroid samples and in an independent dataset (TCGA), evaluating the diagnostic and the prognostic performance of the candidate biomarkers.</s><s>Results: We identified 17 genes significantly differentially expressed between mFTC and wFTC.</s><s>C1QL1, LCN2, CRABP1 and CILP were differentially expressed in DTC in comparison with normal thyroid tissues.</s><s>LCN2 and CRABP1 were also differentially expressed in DTC when compared with follicular thyroid adenoma.</s><s>Additionally, overexpression of LCN2 and C1QL1 were found to be independent predictors of extrathyroidal extension in DTC.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions:</head><p><s>We conclude that the underexpression of CRABP1 and the overexpression of LCN2 may be useful diagnostic biomarkers in thyroid tumours with questionable malignity, and the overexpression of LCN2 and C1QL1 may be useful for prognostic purposes.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p><s>Thyroid cancer is the most frequent type of endocrine cancer with an incidence of 12 cases per 100,000 individuals <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2]</ref>.</s><s>More than 95% of thyroid cancer cases originate from follicular epithelial cells <ref type="bibr" target="#b2">[3]</ref>.</s><s>Papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC) are the most common histotypes.</s><s>Despite the overall good prognosis of these two main histotypes of differentiated thyroid carcinoma (DTC) <ref type="bibr" target="#b0">[1]</ref>, some cases progress, develop distant metastases and acquire an unpredictable response to treatment.</s></p><p><s>The increasing incidence of thyroid cancer has led to the search for good biomarkers that can help in the diagnosis of malignancy and/or predict the clinical behaviour of the tumours.</s><s>Until now, clinical and histopathological prognostic factors remain the only robust elements to be used for diagnosis and prognosis of patients with thyroid tumours <ref type="bibr" target="#b3">[4]</ref>, although new markers are revealing some diagnostic or prognostic value per se.</s><s>As an example, BRAF mutations have been shown to be useful for predicting recurrence and/or disease persistence <ref type="bibr" target="#b4">[5]</ref>, but mostly when associated with other clinicopathological features.</s><s>Recently, TERT promoter mutations revealed an independent prognostic value regarding distant metastasis and survival of patients with thyroid cancer <ref type="bibr" target="#b4">[5]</ref>.</s></p><p><s>The classification of benign and malignant thyroid tumours at the histological level still has limitations.</s><s>Many follicular patterned tumours are typical examples of this difficulty.</s><s>The classical histological criterion to distinguish FTC from follicular thyroid adenoma (FTA) is the presence of any image of capsular or vascular invasion <ref type="bibr" target="#b5">[6]</ref>.</s><s>This circumstance limits the diagnostic accuracy of fine needle aspiration biopsy (FNAB) in pre-surgical grounds.</s><s>FTC is subclassified into minimally invasive FTC (mFTC) and widely invasive FTC (wFTC) <ref type="bibr" target="#b2">[3]</ref>, with the latter having a worse prognosis than mFTC <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b7">8]</ref>.</s><s>The molecular mechanisms that orchestrate the invasiveness of FTC cancer cells are poorly understood.</s></p><p><s>In order to identify molecular alterations associated to thyroid cancer invasion, we used FTC as a model of an encapsulated tumour, studying tumours with different degrees of invasion: two mFTC and two wFTC, using high-throughput paired-end RNA sequencing (RNA-seq) technology.</s><s>The biomarkers proposed here were validated in a series of DTC, in thyroid cancer cell lines and in the gene expression data from DTC available in The Cancer Genome Atlas (TCGA) <ref type="bibr" target="#b8">[9]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Thyroid cancer samples and cell lines</head><p><s>Two wFTC (cases 1 and 2) and two mFTC (cases 3 and 4) were collected from tumour tissue biobank (Porto).</s><s>These four tumours from patients with 55-82 years of age were subjected to high-throughput paired-end RNAseq analyses.</s><s>Briefly, the patient/case 1 had a tumour measuring 2 cm in diameter and presenting a predominant follicular growth pattern and oncocytic features; patient/case 2 had a tumour measuring 5 cm in diameter and presenting a predominant solid/trabecular growth pattern; patient/case 3 had a tumour measuring 3.7 cm in diameter and presenting a follicular growth pattern; and patient/case 4 had a tumour measuring 4 cm in diameter and presenting a follicular growth pattern.</s></p><p><s>For comparative and validation purposes, 137 frozen thyroid samples were collected from tumour tissue biobank (Porto): 98 DTC [15 FTC (including the four used in RNAseq), 23 follicular variant of PTC (FVPTC) and 60 PTC], 20 FTA, and 19 normal samples of adjacent/ contralateral thyroid tissues from patients with DTC from this series.</s><s>The histology of all DTC was revised by two pathologists (CE and MSS) and the final classification was made according to the WHO criteria <ref type="bibr" target="#b2">[3]</ref>.</s><s>The clinicopathological features and genetic alterations of the DTC are presented in Table <ref type="table" target="#tab_0">1</ref>, and a briefly description of the series is available in the Additional file 1.</s><s>Furthermore, ten thyroid cancer cell lines were also used in this study including one cell line derived from one FTC with oncocytic pattern (XTC1), three derived from PTC (BCPAP, K1 and TPC1), and six derived from undifferentiated thyroid carcinoma (C643, HTH74, KAT4, T238, T241, 8505C).</s></p><p><s>High-throughput paired-end RNA-seq Library construction was performed using the TruSeq RNA Sample Prep Kit v2 according to protocol (Illumina Inc., San Diego, CA, USA), including poly-A mRNA isolation, fragmentation, and gel-based size selection.</s><s>Shearing to about 250 bp fragments was achieved using the Covaris S2 focused-ultrasonicator (Covaris Inc., Woburn, MA, USA).</s><s>Sequencing was performed according to the pairedend RNA-seq protocols from Illumina for Solexa sequencing on a Genome Analyzer IIx with paired-end module (Illumina Inc).</s><s>Seventy-six bps were sequenced, from each side of a fragment of about 250 bp long.</s></p><p><s>A particular attention was paid to genes differentially expressed between mFTC and wFTC.</s><s>Reads marked by the Illumina pipeline (Bustard.py,</s><s>OLB 1.6.0 and 1.8.0) as passed filtering were used in the analysis.</s></p><p><s>Gene expression levels in FTCs were computed by using Cufflinks v1.1.0</s><s><ref type="bibr" target="#b9">[10]</ref> with the Illumina iGenomes Ensembl GRCh37 data set (2011-06-20) as reference, on reads aligned with TopHat v1.3.3 <ref type="bibr" target="#b10">[11]</ref>.</s><s>Gene expression levels were compared between the two wFTC (case 1 and 2) and two mFTC (case 3 and 4).</s><s>Results were represented as fold change of gene expression in wFTC comparing with mFTC.</s><s>Values of fold change in gene expression were at logarithmic scale (log2).</s><s>Genes and transcripts were considered differentially expressed between mFTC and wFTC whenever Q value &lt;0.05.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Isolation of nucleic acids, reverse-transcription PCR and cDNA sanger sequencing</head><p><s>Frozen tissue samples available from thyroid tumours (n = 118) and adjacent/collateral normal thyroid tissues (n = 19) were crushed and homogenized.</s><s>Total RNA from tissues and thyroid cancer derived cell lines was extracted using TRIzol® Reagent (Ambion®, Life Technolo-gies™, CA, USA), according to the manufacturer's protocol.</s><s>Genomic DNA was extracted using the Genomic DNA Purification Kit (Citomed, Lisbon, Portugal) according to the manufacturer's protocol.</s></p><p><s>cDNA was synthesized from 1 μg of RNA at 42 °C for 60 min, using oligo (dT) primers and M-MuLV reverse transcriptase (Fermentas, Thermo Scientific, St. Leon-Rot, Germany).</s><s>The reverse-transcription PCR (RT-PCR) products were analysed by cDNA Sanger sequencing using the Big Dye terminator version 3.1 cycle (Applied Biosystems, Foster City, CA, USA).</s><s>The samples were analysed in an automated sequencing machine (ABI Prism 3100 Genetic Analyser, Applied Biosystems, Foster City, CA, USA).</s></p><p><s>Screening for PAX8/PPARG, RET/PTC1 and RET/PTC3 rearrangements, BRAF and NRAS mutations, and TERT promoter mutations in thyroid cancer series</s></p><p><s>The 98 DTC were further characterized for selected molecular alterations known to be common in thyroid tumours.</s><s>PCR followed by Sanger sequencing was used on genomic DNA for detecting mutations in the most frequent hotspot regions of BRAF (exon 15), NRAS (exon 2), and promoter region of TERT, according to previously described procedures <ref type="bibr" target="#b11">[12,</ref><ref type="bibr" target="#b12">13]</ref>.</s><s>In our previous works we verified that HRAS and KRAS mutations were very rare (or absent) events.</s><s>For that reason, we only screened mutations for NRAS gene.</s><s>The presence of PAX8-PPARG and RET/PTC rearrangements were determined by RT-PCR followed by Sanger sequencing of PCR products.</s><s>Some positive cases were confirmed by fluorescence in situ hybridisation (FISH), following the procedures described previously <ref type="bibr" target="#b11">[12]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Real-time quantitative reverse transcription PCR</head><p><s>Real-time quantitative PCR (qPCR) for C1QL1, LCN2, IL22RA1, MAMDC2, CILP, ASXL3, CRABP1, and SCUBE3 genes was performed in the two wFTC (cases 1 and 2) and two mFTC (cases 3 and 4) used in pairedend RNA-seq, and their corresponding normal thyroid tissue.</s><s>qPCR for C1QL1, LCN2, CILP, and CRABP1 were also performed in the remaining series of DTC, in FTA and in normal thyroid tissues, as well as in thyroid cancer cell lines.</s></p><p><s>cDNA was amplified for the C1QL1, LCN2, IL22RA1, MAMDC2, CILP, ASXL3, CRABP1, and SCUBE3 by qPCR using SYBR® Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA).</s><s>A qPCR assay targeting Hypoxanthine phosphoribosyltransferase 1 (HPRT) was used as the housekeeping control.</s><s>Primer sequences are available on request.</s><s>Expression levels were obtained as the average cycle threshold (CT) of at least two replicas.</s><s>A CT = 35 was assigned for target genes that were not expressed in samples with positive expression of the housekeeping control gene (HPRT).</s></p><p><s>The relative quantification of target genes was determined using the comparative CT method (2 -ΔΔCT ) which was previously validated by Livak's Linear Regression Method (Sequence Detector User Bulletin 2; Applied Biosystems) <ref type="bibr" target="#b13">[14]</ref>.</s><s>This provided the fold changes (2 -ΔΔCT ) in gene expression normalized to an internal control gene (HPRT), and relative to one pool of normal thyroid tissues (calibrator).</s><s>Expression values (2 -ΔΔCT ) were normalized at logarithmic scale (log2).</s><s>For C1QL1 and LCN2 genes, fold change [log2 (2 -ΔΔCT )] &gt; 1 was considered as gain of expression, and fold change [log2 (2 -ΔΔCT )] ≤ 1 was established as normal gene expression.</s><s>For CRABP1 and CILP genes, fold change [log2 (2 -ΔΔCT )] &lt; −1 was considered as loss of expression, and fold change [log2 (2 -ΔΔCT )] ≥ −1 was established as normal gene expression.</s><s>The diagnostic performance (sensitivity and specificity) of those cut-off values are presented in Table <ref type="table" target="#tab_1">2</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data from the cancer genomic atlas (TCGA)</head><p><s>RNASeq (version v2) information were extracted from TCGA <ref type="bibr" target="#b14">[15]</ref> for 393 DTC and 59 thyroid normal samples, for C1QL1, LCN2, CRABP1 and CILP genes.</s><s>Gene expression values for each sample are normalized read counts, estimated by using RSEM software <ref type="bibr" target="#b15">[16]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>Statistical analysis was conducted with SPSS version 22.0 (SPSS Inc., Chicago, IL, USA).</s><s>The results are expressed as percentage or mean ± SE.</s><s>Statistical analysis was performed both on the whole DTC series and on the different subgroups: FTC, FVPTC and PTC.</s><s>Receiver Operating Characteristics (ROC) curves for individual biomarkers were generated using log2 (2 -ΔΔCT ) gene expression values and thyroid tissue type (DTC against normal or FTA) as input.</s><s>For evaluation of the combined biomarker panel, the sum of log2 (2 -ΔΔCT ) expression values from genes with gain (C1QL1 and LCN2) and loss (CRABP1 and CILP) in DTC were used.</s><s>Spearman's rho test (non-parametric) was used for evaluating the correlation of the expressions between different genes.</s><s>Fisher's exact test, t-test (unpaired, two-tailed), Mann-Whitney U test, and ANOVA were used when appropriate.</s><s>The predictive value of C1QL1, LCN2, CRABP1 and CILP expression as a prognostic factor in thyroid cancer and their correlation with clinicopathological factorsage, tumour size, and extrathyroidal extension were assessed using univariate and multivariate logistic regression models.</s><s>Test results with P-values &lt;0.05 were considered statistically significant.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Differential gene expression in mFTC and wFTC</head><p><s>Differential expression analysis of the paired-end RNAseq data identified 17 genes with significantly differential expression between mFTC and wFTC (Fig. <ref type="figure">1</ref>, Additional file 2: Table <ref type="table" target="#tab_0">S1</ref> and Additional file 3: Table <ref type="table" target="#tab_1">S2</ref>).</s><s>Increased gene expression of KLK1, NEFL, KIAA1239, SLC6A17, NXPH4, LCN2, C1QL1 and TRIB3, and decreased gene expression of ST6GAL1, SCUBE3, IL22RA1, MAMDC2, CILP, CYSLTR2, ASXL3, CRABP1 and LINC00887 were observed in wFTC in comparison with mFTC.</s><s>C1QL1, LCN2, IL22RA1, MAMDC2, CILP, ASXL3, CRABP1, and SCUBE3 genes were selected for validation through a customized filtering based on gene expression in thyroid tumours and normal thyroid tissues datasets <ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref>, assessed from Oncomine™ and in the literature available.</s><s>Validation of expression levels was done in the four FTCs from paired-end RNA-seq and in their matched normal tissue by qPCR.</s><s>Gain of C1QL1 and LCN2 expression, and loss of IL22RA1, MAMDC2, CILP, ASXL3, CRABP1, and SCUBE3 expression were confirmed in wFTC compared with mFTC and between the four FTC and their respective corresponding normal thyroid tissue (Additional file 4: figure <ref type="figure">S1</ref>).</s><s>Based on the accuracy of gene expression levels obtained from paired-end RNA-seq and qPCR in the FTC and in the gene expression levels in their normal thyroid tissues by qPCR, C1QL1, LCN2, CRABP1 and CILP genes were selected to be tested as biomarkers in a well-characterized series of DTC (Table <ref type="table" target="#tab_0">1</ref>).</s></p><p><s>Additionally, we identified and experimentally verified a set of 21 fusion transcripts expressed by DTC (Additional file 5: figure <ref type="figure" target="#fig_0">S2</ref>; Additional file 6: Table <ref type="table" target="#tab_3">S3</ref>; Additional file 7: Table <ref type="table" target="#tab_4">S4</ref>).</s><s>However, the fusion transcripts are not likely to be biomarkers because they were also detected in normal thyroid tissues.</s><s>Further details can be found in the Additional file 8.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>C1QL1, LCN2, CRABP1, and CILP as biomarkers in DTC</head><p><s>A series of 98 DTC (15 FTC, 23 FVPTC and 60 PTC) and a pool of 19 normal thyroid tissues and 20 FTA were used to evaluate the performance of C1QL1, LCN2, CRABP1, and CILP as biomarkers of DTC.</s><s>Measurements of the expression levels of those genes were done by qPCR.</s><s>C1QL1, LCN2, CRABP1 and CILP were differentially expressed in DTC in comparison with normal thyroid tissues (Additional file 9: figure <ref type="figure">S3</ref>), with statistical significance (P = 0.002, P = 0.005, P &lt; 0.001 and P = 0.018, respectively).</s><s>Notably, such significant differences were also observed for LCN2 and CRABP1 expression when comparing DTC against FTA (P &lt; 0.001 and P = 0.002, respectively), and FTA against normal thyroid tissues (P = 0.013 and P = 0.022, respectively).</s></p><p><s>In order to test the aforementioned biomarkers as putative diagnostic tools for thyroid cancer, ROC curves were performed (Fig. <ref type="figure" target="#fig_0">2</ref>, Additional file 10: Table <ref type="table">S5</ref>).</s><s>In the ROC analysis, comparing DTC versus normal thyroid (Fig. <ref type="figure" target="#fig_0">2a</ref>), the areas under of the ROC curve (AUC) for C1QL1, LCN2, CRABP1 and CILP were 0.799 (P = 2.1E-3), 0.783 (P = 3.6E-3), 0.902 (P = 3.4E-5), and 0.687 (P = 5.5E-2), respectively.</s><s>When these potential biomarkers were combined in a panel of gene expression, the AUC value was 0.927 (P = 1.1E-5) in DTC versus normal thyroid (Fig. <ref type="figure" target="#fig_0">2c</ref>), providing a slight improvement over the AUC results obtained in each individual gene.</s><s>Comparing DTC with FTA, the AUC values for C1QL1, LCN2, CRABP1 and CILP were 0.566 (P = 4.8E-1), 0.898 (P = 1.9E-5), 0.746 (P = 8.3E-3), and 0.675 (P = 6.1E-2), respectively (Fig. <ref type="figure" target="#fig_0">2b</ref>).</s><s>When these potential biomarkers were combined in a panel of gene expression, the AUC value was 0.839 (P = 2.7E-4) in DTC versus FTA (Fig. <ref type="figure" target="#fig_0">2d</ref>), not improving the result in comparison with those of the AUC of LCN2 gene.</s><s>CRABP1 was the best biomarker for Fig. <ref type="figure">1</ref> Differentially expressed genes found between minimally and widely invasive follicular thyroid carcinoma (FTC).</s><s>Gene expression was measured by high-throughput paired-end RNA sequencing and using statistically significant values (Q &lt; 0.05).</s><s>Genes with lower expression in widely invasive FTC as compared with minimally invasive FTC are listed at the top of the figure (green).</s><s>Genes with higher expression in widely invasive FTC as compared with minimally invasive FTC are listed at the bottom of the figure (red).</s><s>Details of genes, expression levels, statistical values, and molecular function of the genes are found in Additional file 2: Table <ref type="table" target="#tab_0">S1</ref> for differentially expressed genes and in Additional file 3: Table <ref type="table" target="#tab_1">S2</ref> for differentially expressed transcripts the detection of DTC when tested against normal thyroid.</s><s>On the other hand, LCN2 was the best biomarker for the detection of DTC when tested against FTA.</s><s>We also tested gene expression levels from an additional series of 393 DTC and 59 normal thyroid tissues available in TCGA <ref type="bibr" target="#b14">[15]</ref>.</s><s>C1QL1, LCN2 and CRABP1 were differentially expressed in DTC in comparison with normal thyroid tissues (Additional file 11: figure <ref type="figure" target="#fig_2">S4</ref>), with statistical significance (P &lt; 0.001).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical and molecular associations with gain of C1QL1 expression</head><p><s>C1QL1 expression levels were successful measured by qPCR in 89 DTC (15 FTC, 20 FVPTC and 54 PTC), 10 thyroid cancer cell lines, 17 FTA, and 18 matched thyroid normal tissues (Fig. <ref type="figure">3a</ref>).</s><s>Gain of C1QL1 expression in relation to thyroid normal tissues was found in FTC, FVPTC and PTC (Fig. <ref type="figure">3b</ref>), but the differences only achieved the threshold of statistical significance in FVPTC (P = 0.015) and PTC (P = 0.001).</s><s>Additionally, eight out of ten (80%) thyroid cancer cell lines showed gain of C1QL1 expression (Fig. <ref type="figure">3c</ref>).</s><s>Gain of C1QL1 expression was significantly associated with extrathyroidal extension (P = 0.003) and lymphocytic thyroiditis (P = 0.003) in the DTC samples (Table <ref type="table" target="#tab_3">3</ref>).</s><s>All the cases with BRAF mutations present gain of C1QL1 expression (P &lt; 0.001).</s><s>In FTC, gain of C1QL1 expression was present in 71% of wFTC and absent in mFTC (P = 0.007; Additional file 12: Table <ref type="table">S6</ref>), and lymphocytic thyroiditis was only present in FTC with gain of C1QL1 expression (P = 0.026).</s><s>In FVPTC, absence of NRAS mutations was significantly associated to the gain of C1QL1 expression (P = 0.014; Additional file 13: Table <ref type="table">S7</ref>).</s><s>PTC with C1QL1 gain were significantly larger (2.96 ± 0.33 cm) than PTC without gain of expression (1.78 ± 0.25 cm; P = 0.021; Additional file 14: Table <ref type="table">S8</ref>).</s><s>Gain of C1QL1 expression in PTC was also significantly associated with the presence of extrathyroidal extension (P = 0.006), and BRAF mutations (P = 0.001).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical and molecular associations with gain of LCN2 expression</head><p><s>LCN2 expression levels were successful measured by qPCR in 86 DTC (14 FTC, 19 FVPTC and 53 PTC), 10 thyroid cancer cell lines, 18 FTA, and 16 matched thyroid normal tissues (Fig. <ref type="figure" target="#fig_2">4a</ref>).</s><s>Gain of LCN2 expression  <ref type="table">S5</ref> was found in FTC, FVPTC and PTC (Fig. <ref type="figure" target="#fig_2">4b</ref>), but the differences only achieved the threshold of statistical significance in PTC (P &lt; 0.001).</s><s>Three out of ten (30%) of the thyroid cancer cell lines showed gain of LCN2 (Fig. <ref type="figure" target="#fig_2">4c</ref>).</s><s>At variance with DTC, significant loss of LCN2 expression was found in FTA (P = 0.013; Fig. <ref type="figure" target="#fig_2">4b</ref>).</s><s>Gain of LCN2 expression in DTC samples was significantly associated with the presence of extrathyroidal extension (P = 0.020), oncocytic features (P = 0.018), and the presence of BRAF mutations (P = 0.031; Table <ref type="table" target="#tab_3">3</ref>).</s><s>Oncocytic pattern of the FTC was significantly associated with the gain of LCN2 expression (P = 0.016; Additional file 12: Table <ref type="table">S6</ref>).</s><s>PTC with gain of LCN2 expression were significantly larger (2.72 ± 0.30 cm) than PTC without gain of expression (1.76 ± 0.34 cm; P = 0.023; Additional file 14: Table <ref type="table">S8</ref>).</s><s>Although not statistically significant (P = 0.130), extrathyroidal extension was more frequent in PTC with gain (54%) than without gain (31%) of LCN2 expression.</s><s>No significant associations that could be related with gain of LCN2 expression were observed in FVPTC.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical and molecular associations with loss of CRABP1 expression</head><p><s>CRABP1 expression levels were successful measured by qPCR in 89 DTC (15 FTC, 19 FVPTC and 55 PTC), 10 thyroid cancer cell lines, 14 FTA, and 19 matched thyroid normal tissues (Fig. <ref type="figure" target="#fig_3">5a</ref>).</s><s>Significant loss of CRABP1 expression was detected in FTC, FVPTC and PTC (P &lt; 0.001), and in FTA (P = 0.023; Fig. <ref type="figure" target="#fig_3">5b</ref>).</s><s>Notably, all the 10 thyroid cancer cell lines tested showed loss of CRABP1 expression (Fig. <ref type="figure" target="#fig_3">5c</ref>).</s><s>Loss of CRABP1 expression was associated with encapsulated DTC (P = 0.037).</s><s>BRAF mutations (P = 0.025; Table <ref type="table" target="#tab_3">3</ref>) were only present in DTC with loss of CRABP1 expression.</s><s>No significant associations were found in FTC, FVPTC and PTC with loss of CRABP1 expression.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical and molecular associations with loss of CILP expression</head><p><s>CILP expression levels were successfully measured by qPCR in 88 DTC (14 FTC, 20 FVPTC and 54 PTC), 10 thyroid cancer cell lines, 17 FTA, and twelve matched   thyroid normal tissues (Fig. <ref type="figure" target="#fig_4">6a</ref>).</s><s>Loss of CILP was detected in FTC, FVPTC and PTC (Fig. <ref type="figure" target="#fig_4">6b</ref>), but differences only attained the threshold of statistical significance in PTC (P = 0.013).</s><s>All the ten thyroid cancer cell lines tested showed loss of CILP expression (Fig. <ref type="figure" target="#fig_4">6c</ref>).</s><s>NRAS mutations (P = 0.001; Table <ref type="table" target="#tab_3">3</ref>) were only present in DTC with loss of CILP expression.</s><s>The same association was also found in FVPTC with loss of CILP expression (P = 0.043).</s><s>No significant associations were found in FTC and PTC with loss of CILP expression.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Association of thyroid cancer risk factors and gene expression</head><p><s>A regression model was performed with C1QL1, LCN2, CRABP1 and CILP expression values for thyroid cancer prognostic factors: age of patients (&gt; 45 years), tumour size (&gt; 4 cm), and presence of extrathyroidal extension of the tumour (Table <ref type="table" target="#tab_4">4</ref>).</s><s>Distant metastasis as prognostic factor was not considered for the computation in the regression models due to the reduced number of thyroid cancers with distant metastasis in the present series.</s></p><p><s>In the univariate analysis, gain of the C1QL1 [odds ratio (OR) = 5.34; P = 0.006] and LCN2 (OR = 3.48; P = 0.029) expression were significantly associated with the extrathyroidal extension of the tumour.</s><s>In the multivariate model, gain of C1QL1 (OR = 4.86; P = 0.011) and LCN2 (OR = 3.39; P = 0.039) expression were independent predictive factors for extrathyroidal extension in DTC.</s><s>Additionally, gain of C1QL1 expression was observed in the larger (&gt; 4 cm) DTC (OR = 4.60), but the difference was only borderline in terms of statistical significance (P = 0.056).</s><s>No associations were found between CRABP1 and CILP expression and prognostic factors of thyroid cancer.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>The clinical behaviour of thyroid cancer is still difficult to predict and clinical and histopathological prognostic factors remain the key elements for diagnosis and prognosis of the patients <ref type="bibr" target="#b3">[4]</ref>.</s><s>Due to the scarcity of molecular biomarkers that can predict the clinical behaviour of thyroid tumours, we used the high-throughput pairedend RNA-seq technology to progress in this subject.</s><s>Until now, few RNA-seq studies on thyroid cancer have been published <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref>, but none in FTC.</s><s>In this pioneering study using FTC as a model, we gave a particular attention towards the identification of genes differentially expressed in mFTC and wFTC.</s></p><p><s>In total, 17 genes were found to be differentially expressed in mFTC and wFTC.</s><s>After customized filtering and validation of expression values by qPCR, C1QL1, LCN2, CRABP1 and CILP genes were selected for further validations in a larger series of DTC, using FTAs and a pool of normal thyroid tissues for comparison.</s></p><p><s>Remarkably, CRABP1 was differentially expressed between DTC, FTA and normal thyroid tissue.</s><s>Expression of CRABP1 was significantly lower in FTC, FVPTC and PTC and in all ten thyroid cancer cell lines than in normal thyroid and FTA.</s><s>In the ROC analysis, AUC for the CRABP1 had the highest value (0.902), in the comparison of DTC versus normal thyroid.</s><s>Gene expression from thyroid samples in TCGA reinforced CRABP1 as biomarker in DTC.</s></p><p><s>CRABP1 (cellular retinoic acid binding protein1) encodes a specific binding protein for a vitamin A family member and is thought to play an important role in retinoic acid-mediated differentiation and proliferation processes.</s><s>Loss of CRABP1 expression in thyroid cancer was shown in previous studies <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b24">25]</ref>, and hypermethylation of CRABP1 promoter CpG islands has been shown as a possible explanation for its reduced expression in thyroid cancer <ref type="bibr" target="#b25">[26]</ref> and in other human cancers <ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref>.</s><s>Our results confirm the potential of CRABP1 as a biomarker of DTC, based in a large number of DTC (n = 89) encompassing several subtypes -FTC, FVPTC and PTC, and controlled by a pool of normal thyroid tissues and of benign tumours -FTA.</s><s>Our results suggest that CRABP1 should be tested in order to see if it may be used in FNAB, for the differential diagnosis of the thyroid nodules displaying morphological features suspicious of malignancy.</s><s>In contrast to results obtained in other human cancers <ref type="bibr" target="#b29">[30,</ref><ref type="bibr" target="#b30">31]</ref>, we did not find any significant association between CRABP1 expression and several well established prognostic factor in thyroid cancer.</s></p><p><s>CILP was found differentially expressed between DTC and normal thyroid tissue.</s><s>Loss of CILP expression was observed in FTC, FVPTC and PTC, but the difference was CILP (cartilage intermediate layer protein) can act as a negative regulator of TGFβ and inhibitory effect of CILP on TGFβ signalling increases with cartilage degeneration <ref type="bibr" target="#b31">[32]</ref>.</s><s>To the best of our knowledge there are no reports on record evidencing a possible relationship between CILP expression and cancer.</s><s>Based on the data obtained in our study, it is not clear that CILP may be used as a good biomarker for DTC in spite of the aforementioned differentiated expression between PTC and normal thyroid tissue.</s><s>The study of a larger series is required to clarify this issue.</s></p><p><s>Similar to the CRABP1, LCN2 was found differentially expressed between DTC, FTA and normal thyroid tissue.</s><s>Gain of LCN2 expression was detected in FTC, FVPTC and PTC, but this gain only obtained the threshold of  LCN2 is a small secreted glycoprotein from the lipocalins family proteins that is important in the protection against bacterial infection and in the modulation of oxidative stress <ref type="bibr" target="#b32">[33]</ref>.</s><s>Consistent with our findings, LCN2 protein overexpression has previously been found in a small series of thyroid cancers <ref type="bibr" target="#b33">[34]</ref>.</s><s>Our data show that higher LCN2 expression (OR = 3.48; P = 0.029) is significantly associated with extrathyroidal extension, a prognostic factor that is strongly associate with progression of thyroid cancer.</s><s>Functional studies in thyroid cancer cell lines also support this assumption; ectopic expression of LCN2 in thyroid cancer cell line leads to an increase of its metastatic behaviour <ref type="bibr" target="#b34">[35]</ref>.</s><s>LCN2 has been indicated as a potential diagnostic and prognostic cancer biomarker in other cancer models [reviewed in <ref type="bibr" target="#b32">[33]</ref>].</s><s>Our results indicate that LCN2 expression may also serve as a useful biomarker in DTC, namely for the FNAB diagnosis of thyroid nodules.</s></p><p><s>C1QL1 was found differentially expressed between DTC and normal thyroid tissue.</s><s>We observed a clear cut gain of C1QL1 expression in FTC, FVPTC and PTC.</s><s>The relative low number of FTC of the present series can justify the lack of statistical significance verified in the comparison of FTC with normal thyroid tissue regarding C1QL1 expression.</s><s>Gain of C1QL1 expression was significantly associated with the presence of extrathyroidal extension in DTC.</s><s>In PTC, tumours with gain of C1QL1 expression were significantly larger than tumours without C1QL1 overexpression.</s><s>Since extrathyroidal extension and tumour size are major prognostic factors of thyroid cancer it may be advance that gain of expression of C1QL1 will probably be a good indicator of clinical evolution.</s><s>Notably, gain of C1QL1 expression was significantly higher in wFTC than in mFTC, reinforcing the assumption that gain of C1QL1 expression is related with thyroid cancer progression.</s><s>Although we found an association of C1QL1 overexpression and lymphocytic thyroiditis in DTC, further statistical analyses revealed no significant differences of C1QL1 expression between the subtypes of DTC with lymphocytic thyroiditis and without lymphocytic thyroiditis (P = 0.316).</s><s>Gene expression from thyroid samples in TCGA reinforced C1QL1 as biomarker in DTC.</s></p><p><s>C1QL1 is member of a subfamily of small secreted proteins of unknown function -C1q-like that are expressed almost exclusively in brain, and produced in differential patterns by specific types of neurons <ref type="bibr" target="#b35">[36]</ref>.</s><s>There are no current reports establishing a possible relation between C1QL1 expression and cancer.</s><s>Despite this, our study showed a significant association between higher C1QL1 expression (OR = 5.34; P = 0.006) and extrathyroidal extension.</s><s>Additionally, gain of C1QL1 expression was observed in the larger (&gt; 4 cm) thyroid cancers (OR = 4.60; P = 0.056), thus reinforcing the importance of C1QL1 expression as predictor of thyroid cancer progression.</s><s>Further studies in larger patient-series are necessary to confirm the statistical significance of our finding with regard to C1QL1 expression.</s></p><p><s>Afirma™ Gene Expression Classifier (GEC) and Thyro-Seq® v.2 are diagnostic tools commercially available and provide accurate classification of most thyroid nodules into benign or malignant in FNAB with undetermined diagnostic <ref type="bibr" target="#b36">[37]</ref><ref type="bibr" target="#b37">[38]</ref><ref type="bibr" target="#b38">[39]</ref><ref type="bibr" target="#b39">[40]</ref><ref type="bibr" target="#b40">[41]</ref>.</s><s>Both assays have high negative (NPV) and/or positive predictive values (PPV) in indicating malignancy of thyroid nodules <ref type="bibr" target="#b38">[39]</ref>.</s><s>These diagnostic tools avoid unnecessary surgeries reducing costs and risks for the patients.</s><s>Although very useful, these technologies are based in a panel of numerous biomarkers, with high costs and not used broadly.</s><s>Additionally, the use of molecular data for predict the prognostic of thyroid cancer patients remains controversial <ref type="bibr" target="#b41">[42]</ref> and the identification of biomarkers with prognostic potential (as we describe here for C1QL1 and LCN2) can further improve the design of this kind of assays.</s><s>Curiously, the Afirma™ GEC and ThyroSeq® v.2 panels do not include any gene validated in our data, reinforcing the relevance and novelty of the biomarkers described here.</s><s>A possible limitation of the present study was the relatively small discovery set used in the RNA-seq analysis, however, to obviate that, the results were validated by RT-PCR in a series of 118 thyroid tumours and 19 normal thyroid samples and by bioinformatics expression analysis in 393 PTC and 59 thyroid normal samples using the TCGA dataset <ref type="bibr" target="#b8">[9]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p><s>In conclusion, we found that expression of the individual genes CRABP1 and LCN2 may be useful biomarkers in DTC, able to improve FNAB differential diagnosis of benign versus malignant tumours.</s><s>We also found that LCN2 and C1QL1 are independent predictors of extrathyroidal extension in DTC.</s><s>The utility of these biomarkers should be evaluated in larger patient series and, in case our findings are confirmed, it will be very interesting to witness the development of tools for the diagnosis and/or prognostic of thyroid cancer using them.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 2</head><label>2</label><figDesc><div><p><s>Fig. 2 Receiver Operating Characteristics (ROC) curves for gene expression of potential biomarkers in thyroid cancers.</s><s>ROC curves for gene expression of individual and combined potential biomarkers in differentiated thyroid cancers (DTC) versus normal thyroid tissues and DTC versus FTA.</s><s>The area under the ROC curve (AUC) represents the accuracy of the individual and combined potential biomarkers for distinguishing differentiated thyroid cancers (DTC) from normal thyroid tissue samples or follicular thyroid adenoma (FTA) (a-d).</s><s>DTC versus normal thyroid for individual (a) and combined (c) potential biomarkers with gain (C1QL1and LCN2) and loss (CRABP1 and CILP) of gene expression in cancer.</s><s>DTC versus FTA for individual (b) and combined (d) potential biomarkers with gain (C1QL1 and LCN2) and loss (CRABP1 and CILP) of gene expression in cancer.</s><s>Asymptotic significance, standard error and 95% confidence interval measurements for all values can be found in Additional file 10: TableS5</s></p></div></figDesc><graphic coords="6,127.28,94.85,340.76,273.77" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 3 Table 3</head><label>33</label><figDesc><div><p><s>Fig. 3 Differential gene expression of C1QL1 in thyroid tumours and normal tissues.</s><s>Gene expression was measured in follicular thyroid adenoma (FTA), follicular thyroid cancer (FTC), follicular variant of papillary thyroid carcinoma (FVPTC), papillary thyroid carcinoma (PTC), normal thyroid tissues and thyroid cancer cell lines by real-time quantitative PCR.</s><s>Histogram showing the gene expression of each sample ordered by expression levels (a).</s><s>Box plot representation (median and Tukey whiskers) showing gene expression of each subgroup of thyroid tumours -FTA, FTC, FVPTC and PTC (b).</s><s>Gene expression of the thyroid cancer cell lines (c).</s><s>Gene expression was calibrated by the pool of normal thyroid tissues.</s><s>Statistically significant values: *P = 0.015, **P = 0.001</s></p></div></figDesc><graphic coords="7,127.28,94.85,340.76,301.89" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 4</head><label>4</label><figDesc><div><p><s>Fig. 4 Differential gene expression of LCN2 in thyroid tumours and normal tissues.</s><s>Gene expression was measured in follicular thyroid adenoma (FTA), follicular thyroid cancer (FTC), follicular variant of papillary thyroid carcinoma (FVPTC), papillary thyroid carcinoma (PTC), normal thyroid tissues and thyroid cancer cell lines by real-time quantitative PCR.</s><s>Histogram showing the gene expression of each sample ordered by expression levels (a).</s><s>Box plot representation (median and Tukey whiskers) showing gene expression of each subgroup of thyroid tumours -FTA, FTC, FVPTC and PTC (b).</s><s>Gene expression of the thyroid cancer cell lines (c).</s><s>Gene expression was calibrated by the pool of normal thyroid tissues.</s><s>Statistically significant values: *P = 0.013 **P &lt; 0.001</s></p></div></figDesc><graphic coords="10,127.28,94.85,340.76,295.14" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 5</head><label>5</label><figDesc><div><p><s>Fig. 5 Differential gene expression of CRABP1 in thyroid tumours and normal tissues.</s><s>Gene expression was measured in follicular thyroid adenoma (FTA), follicular thyroid cancer (FTC), follicular variant of papillary thyroid carcinoma (FVPTC), papillary thyroid carcinoma (PTC), normal thyroid tissues and thyroid cancer cell lines by real-time quantitative PCR.</s><s>Histogram showing the gene expression of each sample ordered by expression levels (a).</s><s>Box plot representation (median and Tukey whiskers) showing gene expression of each subgroup of thyroid tumours -FTA, FTC, FVPTC and PTC (b).</s><s>Gene expression of the thyroid cancer cell lines (c).</s><s>Gene expression was calibrated by the pool of normal thyroid tissues.</s><s>Statistically significant values: *P = 0.023 **P &lt; 0.001</s></p></div></figDesc><graphic coords="11,127.28,94.85,340.76,289.02" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig. 6</head><label>6</label><figDesc><div><p><s>Fig. 6 Differential gene expression of CILP in thyroid tumours and normal tissues.</s><s>Gene expression was measured in follicular thyroid adenoma (FTA), follicular thyroid cancer (FTC), follicular variant of papillary thyroid carcinoma (FVPTC), papillary thyroid carcinoma (PTC), normal thyroid tissues and thyroid cancer cell lines by real-time quantitative PCR.</s><s>Histogram showing the gene expression of each sample ordered by expression levels (a).</s><s>Box plot representation (median and Tukey whiskers) showing gene expression of each subgroup of thyroid tumours -FTA, FTC, FVPTC and PTC (b).</s><s>Gene expression of the thyroid cancer cell lines (c).</s><s>Gene expression was calibrated by the pool of normal thyroid tissues.</s><s>Statistically significant values: *P = 0.013</s></p></div></figDesc><graphic coords="12,127.28,94.85,340.76,292.25" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="5,127.28,488.81,340.76,174.27" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>Clinicopathological and molecular data of patients with differentiated thyroid cancer (DTC) included in the study</s></p></div></figDesc><table><row><cell></cell><cell>Total</cell><cell>FTC</cell><cell>FVPTC</cell><cell>PTC</cell></row><row><cell>Total (%)</cell><cell>98 (100)</cell><cell>15 (15.3)</cell><cell>23 (23.5)</cell><cell>(61.2)</cell></row><row><cell>Age (n)</cell><cell>98</cell><cell>15</cell><cell>23</cell><cell></cell></row><row><cell>Mean (years)</cell><cell>43 ± 1.6</cell><cell>53 ± 3.9</cell><cell>43 ± 3.1</cell><cell>± 2.1</cell></row><row><cell>Tumour size (n)</cell><cell>93</cell><cell>15</cell><cell>22</cell><cell></cell></row><row><cell>Mean (cm)</cell><cell>2.8 ± 0.18</cell><cell>3.9 ± 0.46</cell><cell>2.4 ± 0.30</cell><cell>2.7 ± 0.24</cell></row><row><cell>Gender (n)</cell><cell>98</cell><cell>15</cell><cell>23</cell><cell></cell></row><row><cell>Female (%)</cell><cell>84 (85.7)</cell><cell>12 (80)</cell><cell>19 (82.6)</cell><cell>(88.3)</cell></row><row><cell>Male (%)</cell><cell>14 (14.3)</cell><cell>3 (20)</cell><cell>4 (17.4)</cell><cell>(11.7)</cell></row><row><cell>Capsule (n)</cell><cell>88</cell><cell>15</cell><cell>21</cell><cell></cell></row><row><cell>Positive (%)</cell><cell>45 (51.1)</cell><cell>15 (100)</cell><cell>9 (42.9)</cell><cell>(40.4)</cell></row><row><cell>Capsular invasion (n)</cell><cell>42</cell><cell>15</cell><cell>8</cell><cell></cell></row><row><cell>Positive (%)</cell><cell>27 (64.3)</cell><cell>15 (100)</cell><cell>2 (25.0)</cell><cell>(52.6)</cell></row><row><cell>Vascular invasion (n)</cell><cell>89</cell><cell>15</cell><cell>21</cell><cell></cell></row><row><cell>Positive (%)</cell><cell>48 (53.9)</cell><cell>11 (73)</cell><cell>5 (23.8)</cell><cell>(60.4)</cell></row><row><cell>Lymph node metastasis (n)</cell><cell>93</cell><cell>15</cell><cell>21</cell><cell></cell></row><row><cell>Positive (%)</cell><cell>24 (25.8)</cell><cell>-</cell><cell>4 (19.0)</cell><cell>(35.1)</cell></row><row><cell>Extrathyroidal extension (n)</cell><cell>88</cell><cell>15</cell><cell>21</cell><cell></cell></row><row><cell>Positive (%)</cell><cell>27 (30.7)</cell><cell>1 (6.67)</cell><cell>2 (9.52)</cell><cell>(46.2)</cell></row><row><cell>Distant metastasis (n)</cell><cell>93</cell><cell>15</cell><cell>21</cell><cell></cell></row><row><cell>Positive (%)</cell><cell>5 (5.38)</cell><cell>1 (6.67)</cell><cell>-</cell><cell>(7.02)</cell></row><row><cell>Lymphocytic thyroiditis (n)</cell><cell>91</cell><cell>15</cell><cell>22</cell><cell></cell></row><row><cell>Positive (%)</cell><cell>40 (44.0)</cell><cell>4 (26.7)</cell><cell>8 (36.4)</cell><cell>(51.9)</cell></row><row><cell>Oncocytic (n)</cell><cell>89</cell><cell>15</cell><cell>21</cell><cell></cell></row><row><cell>Positive (%)</cell><cell>17 (19.1)</cell><cell>6 (40.0)</cell><cell>-</cell><cell>(20.8)</cell></row><row><cell>PAX8-PPARG rearrangements (n)</cell><cell>98</cell><cell>15</cell><cell>23</cell><cell></cell></row><row><cell>Positive (%)</cell><cell>2 (2.04)</cell><cell>1 (6.67)</cell><cell>1 (4.35)</cell><cell>-</cell></row><row><cell>RET/PTC rearrangements (n)</cell><cell>98</cell><cell>15</cell><cell>23</cell><cell></cell></row><row><cell>Positive (%)</cell><cell>17 (17.3)</cell><cell>1 (6.67)</cell><cell>3 (13.0)</cell><cell>(21.7)</cell></row><row><cell>RET/PTC1 rearrangement (n)</cell><cell>98</cell><cell>15</cell><cell>23</cell><cell></cell></row><row><cell>Positive (%)</cell><cell>12 (12.2)</cell><cell>1 (6.67)</cell><cell>1 (4.35)</cell><cell>(16.7)</cell></row><row><cell>RET/PTC3 rearrangement (n)</cell><cell>98</cell><cell>15</cell><cell>23</cell><cell></cell></row><row><cell>Positive (%)</cell><cell>2 (2.04)</cell><cell>-</cell><cell>1 (4.35)</cell><cell>(1.67)</cell></row><row><cell>BRAF mutation (n)</cell><cell>98</cell><cell>15</cell><cell>23</cell><cell></cell></row><row><cell>Positive (%)</cell><cell>21 (21.4)</cell><cell>-</cell><cell>2 (8.70)</cell><cell>(31.7)</cell></row><row><cell>NRAS mutation (n)</cell><cell>98</cell><cell>15</cell><cell>23</cell><cell></cell></row><row><cell>Positive (%)</cell><cell>16 (16.3)</cell><cell>5 (33.3)</cell><cell>5 (21.7)</cell><cell>(10.0)</cell></row><row><cell>TERT promoter mutation (n)</cell><cell>98</cell><cell>15</cell><cell>23</cell><cell></cell></row><row><cell>Positive (%)</cell><cell>3 (3.06)</cell><cell>2 (13.3)</cell><cell>1 (4.35)</cell><cell>-</cell></row><row><cell>n, number of cases with available data</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">FTC, follicular thyroid carcinoma; FVPTC, follicular variant of papillary thyroid carcinoma; PTC, papillary thyroid carcinoma</cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc><div><p><s>Diagnostic performance of potential biomarkers for differentiated thyroid cancer (DTC)Sensitivities and specificities are indicated comparing DTC with normal thyroid tissue or follicular thyroid adenoma (FTA)</s></p></div></figDesc><table><row><cell>Biomarker</cell><cell>Cut-off</cell><cell>Sensitivity (%)</cell><cell>Specificity (%)</cell><cell></cell></row><row><cell></cell><cell></cell><cell>DTC</cell><cell>DTC vs normal thyroid</cell><cell>DTC vs FTA</cell></row><row><cell>C1QL1</cell><cell>&gt;1</cell><cell>62.9 (52.0-72.9)</cell><cell>82.4 (56.6-96.0)</cell><cell>58.8 (33.0-81.5)</cell></row><row><cell>LCN2</cell><cell>&gt;1</cell><cell>64.0 (52.9-74.0)</cell><cell>73.3 (44.9-92.1)</cell><cell>83.3 (58.6-96.2)</cell></row><row><cell>CRABP1</cell><cell>&lt;−1</cell><cell>84.3 (75.0-91.1)</cell><cell>88.9 (65.3-98.3)</cell><cell>35.7 (12.9-64.8)</cell></row><row><cell>CILP</cell><cell>&lt;−1</cell><cell>61.4 (50.4-71.6)</cell><cell>66.7 (35.0-89.9)</cell><cell>53.0 (27.9-77.0)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 3</head><label>3</label><figDesc><div><p><s>Clinicopathological and genetic data of differentiated thyroid cancers classified by classes based on gene expression</s></p></div></figDesc><table><row><cell>(Continued)</cell></row></table><note><p><s>n, number of cases with available data; 1, no statistics were computed due to constant numbers of one feature Bold values indicate the result was statistically significant</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 4</head><label>4</label><figDesc><div><p><s>Associations of fold change in gene expression with prognostic factors in differentiated thyroid cancerBold values indicate the result was statistically significant statistical significant in PTC.</s><s>In the ROC analysis, AUC for the LCN2 had the highest value (0.898), in the comparison of DTC versus FTA.</s><s>This finding suggests that LCN2 overexpression may be an interesting biomarker of DTC.</s><s>Gain of LCN2 expression in DTC was significantly associated with the presence of extrathyroidal extension, oncocytic features and presence of BRAF mutation.</s><s>In addition, gain of LCN2 expression in PTC was significantly associated with larger tumour size.</s><s>Gene expression found in thyroid samples from TCGA confirmed LCN2 as biomarker in DTC.</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell>Age (≥ 45 years)</cell><cell></cell><cell cols="2">Tumour size (&gt; 4 cm)</cell><cell cols="2">Extrathyroidal extension</cell></row><row><cell></cell><cell>Expression level</cell><cell>Univariate analysis</cell><cell></cell><cell>Univariate analysis</cell><cell></cell><cell>Univariate analysis</cell><cell></cell><cell>Multivariate analysis</cell></row><row><cell></cell><cell>(fold change)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>OR (95% CI)</cell><cell>P value</cell><cell>OR (95% CI)</cell><cell>P value</cell><cell>OR (95% CI)</cell><cell>P value</cell><cell>OR (95% CI)</cell><cell>P value</cell></row><row><cell cols="2">C1QL1 Gain (&gt;1)</cell><cell>2.02 (0.835-4.88)</cell><cell cols="2">NS (0.119) 4.60 (0.963-21.9)</cell><cell cols="3">NS (0.056) 5.34 (1.63-17.5) 0.006</cell><cell>4.86 (1.43-16.5) 0.011</cell></row><row><cell>LCN2</cell><cell>Gain (&gt;1)</cell><cell>1.17 (0.484-2.83)</cell><cell cols="5">NS (0.726) 0.730 (0.209-2.55) NS (0.622) 3.48 (1.14-10.6) 0.029</cell><cell>3.39 (1.06-10.9) 0.039</cell></row><row><cell cols="2">CRABP1 Loss (&lt;−1)</cell><cell cols="7">0.622 (0.197-1.97) NS (0.419) 1.345 (0.268-6.75) NS (0.719) 1.74 (0.436-6.96) NS (0.432) -</cell><cell>-</cell></row><row><cell>CILP</cell><cell>Loss (&lt;−1)</cell><cell cols="3">0.481 (0.201-1.15) NS (0.100) 2.75 (0.705-10.7)</cell><cell cols="4">NS (0.145) 1.40 (0.530-3.70) NS (0.496) -</cell><cell>-</cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>Not applicable.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Additional files</head><p><s>Additional file 1: Clinicopathological features and genetic alterations of the differentiated thyroid carcinoma (DTC) series.</s><s>(DOCX 12 kb) Additional file 2: Table <ref type="table">S1</ref>.</s><s>Genes differentially expressed between minimally (mFTC) and widely invasive follicular thyroid carcinoma (wFTC).</s><s>(DOCX 14 kb) Additional file 3: Table <ref type="table">S2</ref>.</s><s>Transcripts differentially expressed between minimally (mFTC) and widely invasive follicular thyroid carcinoma (wFTC).</s><s>(DOCX 14 kb) Additional file 4: Figure <ref type="figure">S1</ref>.</s><s>Ratio of cancer/normal tissue gene expression levels of the FTC cases used in RNA-seq.</s><s>Gene expression was measured by real-time quantitative PCR in the FTC (cases 1-4) used in high-throughput paired-end RNA-seq.</s><s>The study was funded by grants from the Research Council of Norway through its Centers of Excellence funding scheme (project number 179571).</s><s>The funding organizations do not have any interference in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Availability of data and materials</head><p><s>The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.</s></p><p><s>Authors' contributions RC, TN, APG, LP, BC, TB, RIS and PS conceived the experiments and analysed data.</s><s>RC, AP and AMH carried out experiments.</s><s>CE and MSS provided the histopathological data.</s><s>RC, MSS, RIS, PS were involved in writing the paper.</s><s>All authors contributed with suggestions and approved the final version of the manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ethics approval and consent to participate</head><p><s>This work was approved by the Ethic Committee for Health (CES) of the Hospital Center of São João (CHSJ) / Faculty of Medicine of the University of Porto (FMUP) (CES 137284-13).</s><s>All the procedures described in this study were in accordance with national ethical standards (Law n°12/2005) and Helsinki declaration.</s><s>All samples from the Biobank were obtained with informed consent from the patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Consent for publication</head><p><s>Not applicable.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Competing interests</head><p><s>The authors declare that they have no competing interests.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Publisher's Note</head><p><s>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</s></p><p><s>Author details</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">SEER data submission</title>
		<author>
			<persName><forename type="first">N</forename><surname>Howlader</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Noone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Krapcho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Neyman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Aminou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Waldron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Altekruse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Kosary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ruhl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Tatalovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mariotto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Eisner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Feuer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Cronin</surname></persName>
		</author>
		<ptr target="http://seer.cancer.gov/csr/1975_2009_pops09" />
	</analytic>
	<monogr>
		<title level="m">SEER Cancer Statistics Review</title>
				<meeting><address><addrLine>Vintage</addrLine></address></meeting>
		<imprint>
			<date type="published" when="1975">1975-2009. 2009. November 2011. April 2012</date>
		</imprint>
		<respStmt>
			<orgName>National Cancer Institute. Bethesda, MD</orgName>
		</respStmt>
	</monogr>
	<note>posted to the SEER web site</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Pathogenetic mechanisms in thyroid follicular-cell neoplasia</title>
		<author>
			<persName><forename type="first">T</forename><surname>Kondo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ezzat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Asa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Cancer</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="292" to="306" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title level="m" type="main">WHO classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Delellis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">V</forename><surname>Lloyd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">U</forename><surname>Heitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Eng</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2004">2004</date>
			<publisher>IARC Press</publisher>
			<pubPlace>Lyon</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Prognostic biomarkers in thyroid cancer</title>
		<author>
			<persName><forename type="first">P</forename><surname>Soares</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Celestino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Melo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Fonseca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sobrinho-Simoes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Virchows Arch</title>
		<imprint>
			<biblScope unit="volume">464</biblScope>
			<biblScope unit="page" from="333" to="346" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas</title>
		<author>
			<persName><forename type="first">M</forename><surname>Melo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Da Rocha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vinagre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Batista</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Peixoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tavares</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Celestino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Almeida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Salgado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Eloy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="E754" to="765" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Genomic differences in benign and malignant follicular thyroid tumours using 1-Mb array-comparative genomic hybridisation</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Qureshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">P</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jani</forename><forename type="middle">P</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Arch Otorhinolaryngol</title>
		<imprint>
			<biblScope unit="volume">270</biblScope>
			<biblScope unit="page" from="325" to="335" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Follicular thyroid carcinoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Sobrinho-Simoes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Eloy</forename><forename type="middle">C</forename><surname>Magalhaes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lobo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Amaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mod Pathol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="S10" to="18" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Minimally invasive (encapsulated) follicular carcinoma of the thyroid gland is the low-risk counterpart of widely invasive follicular carcinoma but not of insular carcinoma</title>
		<author>
			<persName><forename type="first">P</forename><surname>Collini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Sampietro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rosai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pilotti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Virchows Arch</title>
		<imprint>
			<biblScope unit="volume">442</biblScope>
			<biblScope unit="page" from="71" to="76" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Cancer Genome Atlas Research. N. Integrated genomic characterization of papillary thyroid carcinoma</title>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page" from="676" to="690" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation</title>
		<author>
			<persName><forename type="first">C</forename><surname>Trapnell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pertea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mortazavi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kwan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Van Baren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Salzberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Wold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pachter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Biotechnol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="511" to="515" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">TopHat: discovering splice junctions with RNA-Seq</title>
		<author>
			<persName><forename type="first">C</forename><surname>Trapnell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pachter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Salzberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="1105" to="1111" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genes</title>
		<author>
			<persName><forename type="first">R</forename><surname>Celestino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sigstad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lovf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">O</forename><surname>Thomassen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Groholt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Jorgensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Berner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Castro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Lothe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Bjoro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes Chromosomes Cancer</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1154" to="1164" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Frequency of TERT promoter mutations in human cancers</title>
		<author>
			<persName><forename type="first">J</forename><surname>Vinagre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Almeida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Populo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Batista</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lyra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Pinto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Coelho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Celestino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Prazeres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lima</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Commun</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">2185</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Livak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Schmittgen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Methods</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="402" to="408" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma</title>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="676" to="690" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Accurate transcript quantification from RNA-Seq data with or without a reference genome</title>
		<author>
			<persName><forename type="first">B</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cnrsem</forename><surname>Dewey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">323</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Giordano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Y</forename><surname>Au</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kuick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Rhodes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Wilhelm</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vinco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Misek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sanders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="1983" to="1993" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">The role of microRNA genes in papillary thyroid carcinoma</title>
		<author>
			<persName><forename type="first">H</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Jazdzewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Liyanarachchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Nagy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Volinia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Calin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Franssila</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Suster</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="19075" to="19080" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion</title>
		<author>
			<persName><forename type="first">V</forename><surname>Vasko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Espinosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Scouten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Auer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Liyanarachchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Larin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Savchenko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Francis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>De La Chapelle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="2803" to="2808" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Leeman-Neill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Brenner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Little</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">I</forename><surname>Bogdanova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">N</forename><surname>Evdokimova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hatch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">Y</forename><surname>Zurnadzy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Nikiforova</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="799" to="807" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Ricarte-Filho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Garcia-Rendueles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Montero-Conde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Voza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Knauf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Heguy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Viale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Bogdanova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Thomas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="4935" to="4944" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Genomic binding and regulation of gene expression by the thyroid carcinoma-associated PAX8-PPARG fusion protein</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Sartor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Koenig</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncotarget</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="40418" to="40432" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">RNA sequencing identifies multiple fusion transcripts, differentially expressed genes, and reduced expression of immune function genes in BRAF (V600E) mutant vs BRAF wild-type papillary thyroid carcinoma</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Smallridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Chindris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">W</forename><surname>Asmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Casler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Serie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">V</forename><surname>Reddi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Cradic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rivera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Grebe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Necela</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="E338" to="347" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma</title>
		<author>
			<persName><forename type="first">L</forename><surname>Hawthorn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Stein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Varma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wiseman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Loree</forename><forename type="middle">T</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Head Neck</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1069" to="1083" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Increasing the number of thyroid lesions classes in microarray analysis improves the relevance of diagnostic markers</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Fontaine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mirebeau-Prunier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Raharijaona</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Franc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Triau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Rodien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Goeau-Brissonniere</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Karayan-Tapon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Houlgatte</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">e7632</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>De La Chapelle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Pellegata</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="735" to="744" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Comparison of CpG island methylator phenotype (CIMP) frequency in colon cancer using different probe-and gene-specific scoring alternatives on recommended multi-gene panels</title>
		<author>
			<persName><forename type="first">M</forename><surname>Berg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Hagland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Soreide</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">e86657</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">DNA methylation status between breast carcinomatous and normal tissues</title>
		<author>
			<persName><forename type="first">F</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Differential</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomed Pharmacother</title>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma</title>
		<author>
			<persName><forename type="first">K</forename><surname>Tanaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Imoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Inoue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kozaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tsuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shimada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Aiko</forename><forename type="middle">S</forename><surname>Yoshizumi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Iwai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kawano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Inazawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="6456" to="6468" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">CRABP1 provides high malignancy of transformed mesenchymal cells and contributes to the pathogenesis of mesenchymal and neuroendocrine tumors</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Kainov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Favorskaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Delektorskaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Chemeris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Komelkov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zhuravskaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Trukhanova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Zueva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Tavitian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Dyakova</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Cycle</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="1530" to="1539" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">CRABP1-reduced expression is associated with poorer prognosis in serous and clear cell ovarian adenocarcinoma</title>
		<author>
			<persName><forename type="first">T</forename><surname>Miyake</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ueda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Matsuzaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Miyatake</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yoshino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fujita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Nomura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Enomoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kimura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cancer Res Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="page" from="715" to="722" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">A functional SNP in CILP, encoding cartilage intermediate layer protein, is associated with susceptibility to lumbar disc disease</title>
		<author>
			<persName><forename type="first">S</forename><surname>Seki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kawaguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Chiba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Mikami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kizawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Oya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Miyamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Masuda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="607" to="612" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer</title>
		<author>
			<persName><forename type="first">S</forename><surname>Chakraborty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kaur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Guha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Batra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">2012</biblScope>
			<biblScope unit="page" from="129" to="169" />
			<date type="published" when="1826">1826</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">The neutrophil gelatinaseassociated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells</title>
		<author>
			<persName><forename type="first">A</forename><surname>Iannetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Pacifico</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Acquaviva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lavorgna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Crescenzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Vascotto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Salzano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Scaloni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Vuttariello</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="14058" to="14063" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Controls the metastatic potential of anaplastic thyroid carcinoma cells</title>
		<author>
			<persName><forename type="first">V</forename><surname>Volpe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Raia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sanguigno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Somma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mastrovito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Moscato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mellone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Leonardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Fngal</forename><surname>Pacifico</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="228" to="235" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Distinct expression of C1q-like family mRNAs in mouse brain and biochemical characterization of their encoded proteins</title>
		<author>
			<persName><forename type="first">T</forename><surname>Iijima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Miura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Watanabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yuzaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Neurosci</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="1606" to="1615" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Preoperative diagnosis of benign thyroid nodules with indeterminate cytology</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">K</forename><surname>Alexander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Kennedy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">W</forename><surname>Baloch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Cibas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Chudova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Diggans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Friedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Kloos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>Livolsi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Mandel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">367</biblScope>
			<biblScope unit="page" from="705" to="715" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Multicenter clinical experience with the Afirma gene expression classifier</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">K</forename><surname>Alexander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schorr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Klopper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sipos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Nabhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Steward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Mandel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Haugen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="119" to="125" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Impact of the multi-gene ThyroSeq next-generation sequencing assay on cancer diagnosis in thyroid nodules with atypia of undetermined significance/follicular lesion of undetermined significance cytology</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">E</forename><surname>Nikiforov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Carty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Chiosea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Coyne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Duvvuri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Ferris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Gooding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">O</forename><surname>Lebeau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">P</forename><surname>Ohori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Seethala</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Thyroid</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="1217" to="1223" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">E</forename><surname>Nikiforov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Carty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Chiosea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Coyne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Duvvuri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Ferris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Gooding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Hodak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">O</forename><surname>Lebeau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">P</forename><surname>Ohori</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="3627" to="3634" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules</title>
		<author>
			<persName><forename type="first">B</forename><surname>Mciver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Castro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Bernet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Smallridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Henry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kosok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Reddi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="4069" to="4077" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Genomic profiling of thyroid nodules: current role for ThyroSeq next-generation sequencing on clinical decisionmaking</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Y</forename><surname>Kargi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Bustamante</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gulec</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Imaging Radionucl Ther</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="24" to="35" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
